trx-818
Small moleculeexperimental
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2015 (NCT02507544)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- trx-818
- trx-818
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05257590 | Phase 2 | May 31, 2022 | National Taiwan University, TaiRx, Inc. |
| NCT03600233 | Phase 2 | Nov 30, 2018 | TaiRx, Inc. |
| NCT03582618 | Phase 2 | Jul 12, 2018 | TaiRx, Inc. |
| NCT02703298 | Phase 1 | Mar 1, 2016 | National Cheng Kung University, TaiRx, Inc. |
| NCT02507544 | Phase 1 | Sep 1, 2015 | South Texas Accelerated Research Therapeutics, TaiRx, Inc. |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| TaiRx, Inc. | For profit | 5 | 5 | 2 | 2015 |
| National Cheng Kung University | Academic/Hospital | 1 | 0 | 1 | 2016 |
| National Taiwan University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| South Texas Accelerated Research Therapeutics | For profit | 1 | 0 | 1 | 2015 |
4 organizations
Page 1 / 1